SeSDERMA Laboratories, an international cosmeceuticals company, recently introduced a new product for the non-injectable filler market at the October meeting of the International Congress of Aesthetics. FillDerma™ is a two-part treatment system which smoothes wrinkles using a combination of oil-based microspheres to penetrate and expand under the skin when hydrated, and an activator gel which contains matrixyl, a component popularly used as a collagen stimulator. FillDerma can be used alone or as a complement to Botox®, collagen, and other injectables.
Dr. Gabriel Serrano, founder of SeSDERMA Laboratories, worked with Dr. Gerard Robert of Lyon, France, to develop FillDerma. SeSDERMA Laboratories was the first European laboratory to introduce products containing glycolic acid and other
alphahydroxy acids and now has more than 150 products in the line which are sold only through physicians.
For more information on SeSDERMA Laboratories or the FillDerma product line, contact Raimundo Sala, Director of North
American Sales for SeSDERMA USA, at raimundo@sesdermausa.com.
SeSDERMA USA
404.846.2044
www.sesdermausa.com




